Psilocybin at a Regulatory Crossroads: Five Unresolved Questions Shaping the Future of Psychedelic Medicine Denis Katz, M.D. Founder & Medical Director, Salience Clinical LLC Introduction The optimism surrounding psilocybin is not unfounded. Early clinical findings have been striking enough to attract serious scientific attention, substantial investment, and a level of public interest...